Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Pothuri, Bhavana; Secord, Angeles Alvarez; Armstrong, Deborah K.; Chan, John K.; Fader, Amanda N.; Huh, Warner K.; Kesterson, Joshua; Liu, Joyce F.; Moore, Kathleen N.; Westin, Shannon N.; Naumann, R. Wendel

doi:10.1016/j.ygyno.2020.04.694

Cited by 50 publications

(68 citation statements)

References 88 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the last months, proposals for triage in several health conditions have been published especially in oncology including skin cancer. [4][5][6][7][8][9] BADO developed recommendations to prioritize dermato-oncological care on a national level in Belgium. In the circumstances of the COVID19 pandemic, the approval and refunding of tele/videoconsultations by the government was accelerated but for skin cancer treatment and follow-up teleconsultations are often suboptimal.…”

mentioning

confidence: 99%

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Brochez

Baurain

Marmol

et al. 2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Brochez

Baurain

Marmol

et al. 2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…This is in keeping with cancer guidance of referral to treatment of 30 day cutoff in most developed countries for starting active intervention from diagnosis and also the time frame for advocating adjuvant therapy. [14][15][16] As expected, the response rate to either postponement or modifications in 'follow-up' of treated patients was high. Despite many years of discussion, there is always resistance to change traditional physical follow up methods all over the world.…”

Section: Resultsmentioning

confidence: 60%

“…There is an increased risk of acquiring viral infection as Radiotherapy needs multiple visits to hospital and chemotherapy suppresses immunity and increases susceptibility to infection. [13,14]There might have been obvious logistic reasons for following one treatment over the other, such as lack of availability of slots to treat, inability to travel to a center with RT or surgical facility or reduced number of medical/nursing staff working due to quarantine and lockdown issues. The overall oncological outcomes of early gynecological cancers is very good hence needs to be evaluated and compared to pre COVID literature as there are deviations in standard management during this pandemic all over the world.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Impact of COVID-19 pandemic on gynecological oncology care: Glimpse into Association of Gynecological Oncologists of India (AGOI) perspective

Bhandoria

Shylasree

Bhandarkar

et al. 2020

Preprint

View full text Add to dashboard Cite

Purpose: The notorious COVID 19 pandemic has caused rapid and drastic changes in cancer care all over the world in 2020. This online survey aims to assess the extent to which the pandemic has affected cancer care in gynecological oncology amongst members of Association of Gynecological Oncologists of India (AGOI), a registered professional society, founded in 1991. Methods: We developed and administered a cross-sectional, flash survey to members of The Association of Gynecological Oncologists of India (AGOI) in the first week of April 2020. Data were analyzed using Microsoft Office Excel 2016. Results were expressed as percentages of total responses excluding blank or unattended response. Overall theme-specific responses were expressed as a spectrum of finding and related inferences were drawn.Results: Among approached practitioners, 90 responded to the survey, more than 80 % were practicing consultants and more than 50 % from academic institutions. Results of the survey showed that the ongoing pandemic had severely affected gynecological oncology practice and care amongst all responders. There were modifications in diagnostic pathways, interventions and follow ups across all organ sites. There was near unanimous opinion on use of general safety measures to combat the virus and to use complete PPEs in high risk situation. There was mixed responses to alternative educational activities especially using electronic technology and distant learning methods. There was an optimism among responders with regards to the current situation normalizing in 3 to 6 months. Conclusion: This study documents the pandemic affected scenario of gynecological cancer care and perceptions of Gynecological Oncologists in India. Significant effect on all aspects of cancer care were observed. Technological learning methods both for patient care and educational activities were being adopted by many responders. Keywords: COVID-19, pandemic, gynecological oncology care, survey, AGOI

show abstract

“…There are several guidelines published to give recommendations on the safe gynecologic practice and the treatment of gynecologic patients during the ongoing pandemic, focusing onthe management of cancer patients [7][8][9][10][11][12]. Whenthe outbreak peak is gone and the lockdown is lifted, the medical resources should be redirected to none-COVID-19 patients, while the threats of COVID-19 transmission still exist.…”

Section: Introductionmentioning

confidence: 99%

Resumption of the Treatment for Non-COVID-19 Gynecologic Patients after Lifting Lock down: Experiences from Wuhan

Dong

Gao

Cai

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: To share our experiences of resumption of the treatment for gynecologic patients after lifting lockdown in a hotspot area of the Corona Virus Disease 2019 (COVID-19)pandemic.Methods: The triage process used to resume the medical activities for gynecologic patients at the Wuhan Union Hospital after a 76-day lockdown of the city is described and its effectiveness to avoid COVID-19 nosocomial transmission is shown.Results:The non-emergency patients are pre-triaged by contact history and body temperature at outpatient clinic and negative COVID-19 screening tests are required for an admissionin the buffering rooms at the gynecologic department. The buffering lastsfor at least three days for symptom monitoring and a second round of COVID-19 tests before they can be transferred to the regular gynecologic wards. For patients who need emergency surgery, the first screening should be completed at the quarantine wards after the surgery, followed by buffering at the gynecologic department. We received 19298 outpatient visits, admitted 326 patients, and performed 223 operations in the first two months after the lockdown was lifted, andno single COVID-19 case occurredin the hospitalized patients while the proportion of potentially high-risk patients with cancer and severe anemia were increased in comparison with the same period in 2019 and the latest two months before the lockdown.Conclusions:We provide an effective triage system with buffering at two levels to guarantee safe and timely treatment for non-COVID-19 gynecologic patients in a post-lockdown phase.

show abstract

Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis

Abstract: The world wide COVID-19 pandemic has limited cancer care and clinical trials.• Strategies should be employed to limit contact points with health care facilities.• All care should consider the risks of cancer care balanced against the risk of COVID-19 infection.

Cited by 50 publications

References 88 publications

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Impact of COVID-19 pandemic on gynecological oncology care: Glimpse into Association of Gynecological Oncologists of India (AGOI) perspective

Resumption of the Treatment for Non-COVID-19 Gynecologic Patients after Lifting Lock down: Experiences from Wuhan

Contact Info

Product

Resources

About